key: cord-0877212-ux4tausq
authors: Tang, Wei; Lu, Jing; Song, Qiao-Yun; Li, Man-Mei; Chen, Li-Feng; Hu, Li-Jun; Yang, Shao-Min; Zhang, Dong-Mei; Wang, Ying; Li, Yao-Lan; Ye, Wen-Cai
title: Discovery of rhodomyrtone as a broad-spectrum antiviral inhibitor with anti-SARS-CoV-2 activity
date: 2020-11-16
journal: bioRxiv
DOI: 10.1101/2020.11.14.382770
sha: 79e02c6cc39636d85a11c65b3912d3013ba834d4
doc_id: 877212
cord_uid: ux4tausq

The outbreak of new viruses, such as serve acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as the emerging of drug-resistance viruses highlight the urgent need for the development of broad-spectrum antiviral drugs. Herein, we report the discovery of a plant-derived small molecule, 6,8-dihydroxy-9-isobutyl-2,2,4,4-tetramethyl-7-(3-methylbutanoyl)-4,9-dihydro-1H-xanthene-1,3(2H)-dione (rhodomyrtone, RDT), which exhibited potent broad-spectrum antiviral activities against several RNA and DNA viruses, including SARS-CoV-2, respiratory syncytial virus (RSV), herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2), varicella-zoster virus (VZV), human cytomegalovirus (HCMV), and Kaposi’s sarcoma-associated herpesvirus (KSHV). RDT can significantly suppress viral gene expression and show the low possibility to elicit drug-resistant variants. Mechanistic study implied that RDT inhibited viral infection by disturbing the cellular factors that essential for viral gene expression. Our results suggested that RDT might be a promising lead compound for the development of broad-spectrum antiviral drugs.

Abstract 23 The outbreak of new viruses, such as serve acute respiratory syndrome 24 coronavirus 2 (SARS-CoV-2), as well as the emerging of drug-resistance viruses 25 highlight the urgent need for the development of broad-spectrum antiviral drugs. 26 Herein, we report the discovery of a plant-derived small molecule, 27 6,8-dihydroxy-9-isobutyl-2,2,4,4-tetramethyl-7-(3-methylbutanoyl)-4,9-dihydro-1H- We found that HSV-1/Blue virus, a TK mutant variant, showed strong resistance to 89 ACV but sensitive to RDT. The virus-induced plaques were significantly inhibited by 90 the treatment of RDT at the concentrations from 0.5 to 2 μM, however, the plaque 91 formation was not affected by ACV even at the concentration of 20 μM (Fig. 2a) . In (Fig. 2b) . 96 These results indicated that the action mechanism of RDT is distinct from that of 97 ACV. 98 The results of immunofluorescence and RT-PCR assay demonstrated that RDT 99 potently suppressed the viral gene expression in a concentration-dependent manner 100 ( Fig. 2c-d) . Interestingly, the transcription level of US6 (gD) that inserted in a 101 pcDNA3.1(+) plasmid was decreased after the treatment of RDT in the cells, 102 particularly significantly decreased in the cytoplasm (Fig. 2e-f ). Next, we observed 103 that the distribution of NXF1/TAP, a cellular mRNA export receptor, in the cytoplasm 104 was inhibited by RDT treatment, suggesting an inhibitory effect of RDT on mRNA 105 export (Fig. 2g) . To determine whether the mRNA export pathway was affected by 106 RDT, we inserted Aly/Ref, a cellular mRNA export adaptor, and NXF1/TAP into 107 pEGFP-N3 and pmCherry-N1 plasmids, respectively. The results in confocal assay 108 demonstrated that NXF1/TAP-mCherry was co-localized with Aly/Ref-EGFP in the 109 cells, however, their interaction was affected by the treatment of RDT (Fig. 2h) . 

Treatment failure and resistance with direct-acting antiviral 224 drugs against hepatitis C virus

Approved Antiviral Drugs over the Past 50 Years

Candidate drugs against SARS-CoV-2 and COVID-19

Update on therapeutic approaches and emerging therapies 231 for SARS-CoV-2 virus

The Impact of Mutations in SARS-CoV-2 Spike on Viral 234 Infectivity and Antigenicity

Adducts from Cleistocalyx operculatus

Small molecule inhibits respiratory syncytial virus entry and 240 infection by blocking the interaction of the viral fusion protein with the cell 241 membrane

Cleistocalyx operculatus and Their in Vitro Antiviral Activity

Antiviral activity of ethanol extract of Lophatherum gracile 246 against respiratory syncytial virus infection

Inhibitory Effect of PIK-24 on Respiratory Syncytial Virus 249 Entry by Blocking Phosphatidylinositol-3 Kinase Signaling

Potential antibiotic and anti-infective effects of 252 rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. on Streptococcus 253 pyogenes as revealed by proteomics

Rhodomyrtone: a new candidate as natural antibacterial 256 drug from Rhodomyrtus tomentosa

Inactivation of farR Causes High Rhodomyrtone 259 Resistance and Increased Pathogenicity in Staphylococcus aureus

Microbiol 10